NextSDS Logo
Chemical Substance

(2S,3S,4S,5R,6R)-6-[[(3S,4S,4aR,6aR,6bS,8R,8aR,9R,10R,12aS,14aR,14bR)-9-acetyloxy-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(Z)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-hydroxy-3,5-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxane-2-carboxylic acid

CAS Number 11072-93-8
EC Number 600-985-2
Molecular Formula C55H86O24
SDS management

Is this substance in your SDS library?

NextSDS finds every safety data sheet that contains it, flags new hazard classifications and keeps your whole SDS library current for every site.

Book a demo See SDS management

Identifiers

Cas Number 11072-93-8 Primary
Ec Number 600-985-2
Chemical Name beta-Escin
Chemical Name (2S,3S,4S,5R,6R)-6-[[(3S,4S,4aR,6aR,6bS,8R,8aR,9R,10R,12aS,14aR,14bR)-9-acetyloxy-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(Z)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-hydroxy-3,5-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxane-2-carboxylic acid

GHS Hazard Pictograms

GHS07 Hazard Pictogram GHS07
GHS09 Hazard Pictogram GHS09

Hazard Classifications

Acute Tox. 4
Acute toxicity (oral + dermal + inhalation)
Warning
Hazard Code H302 + H312 + H332
Category Acute Tox. 4
Source: Notified C&L
Eye Irrit. 2
Eye irritation
Warning
Hazard Code H319
Category Eye Irrit. 2
Source: Notified C&L
STOT SE 3
Specific target organ toxicity — single exposure
Warning
Hazard Code H336
Category STOT SE 3
Source: Notified C&L
Aquatic Chronic 2
Hazardous to the aquatic environment (long-term)
Hazard Code H411
Category Aquatic Chronic 2
Source: Notified C&L

Related Substances

(2S,3R,4S,5R,6R)-2-[(2S,3R,4S,5S,6R)-2-[[(4R,4aR,6aR,6bS,8R,8aS,12aR,1 4S,14aS,14bS)-8-hydroxy-4,8a-bis(hydroxymethyl)-14-methoxy-4,6a,6b,11, 11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropi cen-3-yl]oxy]-5-hydroxy-6-methyl-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy- 6-(hydroxymethyl)oxan-2-yl]oxy-oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3, 4,5-triol
146519-04-2
[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (4aS,6a S,6aS,6bR,10S,12aS,14bS)-10-[(2R,3R,4S,5R,6R)-5-hydroxy-6-(hydroxymeth yl)-3,4-bis[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2 -yl]oxy]oxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8 a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate
144077-05-4
[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (4aS,6a S,6aS,6bR,10S,12aS,14bS)-10-[(2S,3R,4S,5S)-5-hydroxy-4-[(2S,3R,4S,5R,6 R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3R,4S,5R)-3, 4,5-trihydroxyoxan-2-yl]oxy-oxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethy l-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxyl ate
144118-18-3
[(2S,3R,4S,5S)-3-[(2S,3R,4S,5R,6S)-5-[(2S,3R,4S,5R)-4-[(2S,3R,4R)-3,4-Dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl] (4aR,5R,6aR,6aS,6bR,8aR,10R,11S,12aR,14bS)-5,11-dihydroxy-9,9-bis(hydroxymethyl)-2,2,6a,6b,12a-pentamethyl-10-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate
58479-68-8
6-[[11-carboxy-9-[4,5-dihydroxy-3-[2,4,5-trihydroxy-6-(hydroxymethyl)o xan-3-yl]oxy-oxan-2-yl]oxy-4-(hydroxymethyl)-4,6a,6b,8a,11,14b-hexamet hyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]- 5-[4,5-dihydroxy-6-(hydroxymethyl)-3-(3,4,5-trihydroxy-6-methyl-oxan-2 -yl)oxy-oxan-2-yl]oxy-3,4-dihydroxy-oxane-2-carboxylic acid
147666-63-5

Disclaimer

The substance data provided is sourced from various third-party databases and regulatory sources. While we strive to maintain accuracy, we cannot guarantee the completeness, accuracy, or timeliness of this information. Users are responsible for verifying all data before use in compliance, safety, or regulatory contexts. NextSDS is not liable for any decisions made based on this data.